A Dose-Ranging Study of Intravenous BNZ132-1-40 in Patients with Large Granular Lymphocyte Leukemia or Cutaneous T-Cell Lymphoma

IRB/UVA Tracking #
20347
Contact
Kim M Underwood
Contact Email
Contact Phone
1.434.982.3947
Phase
I/II
Primary purpose
Treatment
Cancer PI
Karen Ballen
Status
OPEN TO ACCRUAL
Ages
Adult